Literature DB >> 18528551

The influence of hypoxia on bioluminescence in luciferase-transfected gliosarcoma tumor cells in vitro.

Eduardo H Moriyama1, Mark J Niedre, Mark T Jarvi, Joseph D Mocanu, Yumi Moriyama, Patrick Subarsky, Buhong Li, Lothar D Lilge, Brian C Wilson.   

Abstract

Firefly luciferase catalyzes the emission of light from luciferin in the presence of oxygen and adenosine triphosphate. This bioluminescence is commonly employed in imaging mode to monitor tumor growth and treatment responses in vivo. A potential concern is that, since solid tumors are often hypoxic, either constitutively and/or as a result of treatment, the oxygen available for the bioluminescence reaction could be reduced to limiting levels, leading to underestimation of the actual number of luciferase-labeled cells during in vivo experiments. We present studies of the oxygen dependence of bioluminescence in vitro in rat 9 L gliosarcoma cells tagged with the firefly luciferase gene (9L(luc)). We demonstrate that the bioluminescence signal decreases at pO(2) <or= 5%, falling by approximately 50% at 0.2% pO(2). Further experiments showed that the critical threshold for the initiation of metabolic depression in these cells was around 5%. Below this level, the decrease of oxygen saturation was followed by a decrease in intracellular ATP due to the reduction of mitochondrial membrane potential. Hence, the data suggest that the decrease of intracellular ATP level in vitro is the limiting factor for bioluminescence reaction and so is responsible for the reduction of bioluminescence signal in 9L(luc) cells in acute hypoxia, rather than luciferase expression or oxygen itself.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528551     DOI: 10.1039/b719231b

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  21 in total

1.  ATP-binding cassette transporters modulate both coelenterazine- and D-luciferin-based bioluminescence imaging.

Authors:  Ruimin Huang; Jelena Vider; Inna Serganova; Ronald G Blasberg
Journal:  Mol Imaging       Date:  2011-06       Impact factor: 4.488

Review 2.  Non-invasive molecular imaging for preclinical cancer therapeutic development.

Authors:  A C O'Farrell; S D Shnyder; G Marston; P L Coletta; J H Gill
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

3.  In vivo bioluminescent tracking of mesenchymal stem cells within large hydrogel constructs.

Authors:  Ashley B Allen; Zulma Gazit; Susan Su; Hazel Y Stevens; Robert E Guldberg
Journal:  Tissue Eng Part C Methods       Date:  2014-04-03       Impact factor: 3.056

4.  Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

Authors:  Michelle Cronin; David Morrissey; Simon Rajendran; Shereen M El Mashad; Douwe van Sinderen; Gerald C O'Sullivan; Mark Tangney
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

Review 5.  In vivo bioluminescence for tracking cell fate and function.

Authors:  Patricia E de Almeida; Juliaan R M van Rappard; Joseph C Wu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

6.  Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases.

Authors:  Karianne G Fleten; Kine M Bakke; Gunhild M Mælandsmo; Andreas Abildgaard; Kathrine Røe Redalen; Kjersti Flatmark
Journal:  Clin Exp Metastasis       Date:  2016-11-03       Impact factor: 5.150

7.  Bioluminescence: a versatile technique for imaging cellular and molecular features.

Authors:  Miranda A Paley; Jennifer A Prescher
Journal:  Medchemcomm       Date:  2013-12-13       Impact factor: 3.597

8.  In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis.

Authors:  Oumaïma Ibrahim-Granet; Grégory Jouvion; Tobias M Hohl; Sabrina Droin-Bergère; François Philippart; Oh Yoen Kim; Minou Adib-Conquy; Reto Schwendener; Jean-Marc Cavaillon; Matthias Brock
Journal:  BMC Microbiol       Date:  2010-04-08       Impact factor: 3.605

9.  Enhanced susceptibility to urinary tract infection in the spinal cord-injured host with neurogenic bladder.

Authors:  Zarine R Balsara; Sherry S Ross; Paul C Dolber; John S Wiener; Yuping Tang; Patrick C Seed
Journal:  Infect Immun       Date:  2013-06-10       Impact factor: 3.441

10.  Influence of bioluminescence imaging dynamics by D-luciferin uptake and efflux mechanisms.

Authors:  Yimao Zhang; Mrudula Pullambhatla; John Laterra; Martin G Pomper
Journal:  Mol Imaging       Date:  2012 Nov-Dec       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.